drugset

drugset / Trial / NCT00372931

A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00372931 ↗

Phase 2 Completed 120 enrolled Alcon Research

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether AL-37807 is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Timeline

Start: 2006-05
Primary completion: 2007-08
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AL-37807	Unknown	—	—

Indications